Tmod engineered T cells(A2 Biotherapeutics/Merck Research Laboratories)

N/A

Report date: 2025/01/26 16:15:02

Base Information

Drug NameTmod engineered T cells(A2 Biotherapeutics/Merck Research Laboratories)
Drug Alias Namegenetically engineered allogeneic cell therapy(A2 Biotherapeutics/Merck Research Laboratories)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesA2 Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck Research LaboratoriesA2 Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A